Adult -Screener for pretest

Experimental Study of Cigarette Warnings

Email to Adults

Adult -Screener for pretest

OMB: 0910-0866

Document [docx]
Download: docx | pdf

OMB #0910-NEW

Expires XX/YY/20XX


Experimental Study of Cigarette Warning Labels

Email to Adults for Study Participation

Screener & Session 1


Greetings!

We have a new survey and your participation is requested. The survey is meant for adults aged 18 and older. If you qualify and complete the survey, your Global Test Market account will be credited with the Lifepoints stated in the invitation.



Please note that this survey must be taken on a desktop or laptop computer.



A new survey is available

Survey Number: [INSERT SURVEY #]

Reward for Survey Completion: 1,000 Lifepoints

Shape1

Start Now!






You may also access the survey by copying the following URL into your browser: [INSERT URL LINK]




Best Regards –

Global Test Market Team



[GO TO ADULT CONSENT (SESSION 1)]



OMB #0910-NEW

Expires XX/YY/20XX




Paperwork Reduction Act Statement: The public reporting burden for this information collection has been estimated to average 2 minutes per response to complete this screener survey (the time estimated to read and complete) and 12 minutes per response to complete the Session 1 survey (the time estimated to read and complete), if the participant qualifies. Send comments regarding this burden estimate or any other aspects of this information collection, including suggestions for reducing burden, to PRAStaff@fda.hhs.gov.



Experimental Study of Cigarette Warning Labels

Email to Adults for Study Participation

Session 2



Greetings!

We have a new survey and your participation is requested. The survey is meant for adults aged 18 and older. This is a follow-up survey to a survey you completed a few days ago, so you are already qualified to complete this survey. If you complete this survey, your Global Test Market account will be credited with the Lifepoints stated in the invitation.



Please note that this survey must be taken on a desktop or laptop computer.



A new survey is available

Survey Number: [INSERT SURVEY #]

Reward for Survey Completion: 1,000 Lifepoints

Shape2

Start Now!






You may also access the survey by copying the following URL into your browser: [INSERT URL LINK]




Best Regards –

Global Test Market Team



[GO TO ADULT CONSENT (SESSION 2)]



OMB #0910-NEW

Expires XX/YY/20XX




Paperwork Reduction Act Statement: The public reporting burden for this information collection has been estimated to average 8 minutes per response to complete this survey (the time estimated to read and complete). Send comments regarding this burden estimate or any other aspects of this information collection, including suggestions for reducing burden, to PRAStaff@fda.hhs.gov.





Experimental Study of Cigarette Warning Labels

Email to Adults for Study Participation

Session 3



Greetings!

We have a new survey and your participation is requested. The survey is meant for adults aged 18 and older. This is a follow-up survey to a survey you completed a few weeks ago, so you are already qualified to complete this survey. If you complete this survey, your Global Test Market account will be credited with the Lifepoints stated in the invitation.



Please note that this survey must be taken on a desktop or laptop computer.

A new survey is available

Survey Number: [INSERT SURVEY #]

Reward for Survey Completion: 1,000 Lifepoints

Shape3

Start Now!






You may also access the survey by copying the following URL into your browser: [INSERT URL LINK]




Best Regards –

Global Test Market Team



[GO TO ADULT CONSENT (SESSION 3)]



OMB #0910-NEW

Expires XX/YY/20XX




Paperwork Reduction Act Statement: The public reporting burden for this information collection has been estimated to average 5 minutes per response to complete this survey (the time estimated to read and complete). Send comments regarding this burden estimate or any other aspects of this information collection, including suggestions for reducing burden, to PRAStaff@fda.hhs.gov.

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorSYSTEM
File Modified0000-00-00
File Created2021-01-15

© 2024 OMB.report | Privacy Policy